Literature DB >> 20647992

Host-pathogen interactions in urinary tract infection.

Greta R Nielubowicz1, Harry L T Mobley.   

Abstract

The urinary tract is a common site of bacterial infections; nearly half of all women experience at least one urinary tract infection (UTI) during their lifetime. These infections are classified based on the condition of the host. Uncomplicated infections affect otherwise healthy individuals and are most commonly caused by uropathogenic Escherichia coli, whereas complicated infections affect patients with underlying difficulties, such as a urinary tract abnormality or catheterization, and are commonly caused by species such as Proteus mirabilis. Virulence and fitness factors produced by both pathogens include fimbriae, toxins, flagella, iron acquisition systems, and proteins that function in immune evasion. Additional factors that contribute to infection include the formation of intracellular bacterial communities by E. coli and the production of urease by P. mirabilis, which can result in urinary stone formation. Innate immune responses are induced or mediated by pattern recognition receptors, antimicrobial peptides, and neutrophils. The adaptive immune response to UTI is less well understood. Host factors TLR4 and CXCR1 are implicated in disease outcome and susceptibility, respectively. Low levels of TLR4 are associated with asymptomatic bacteriuria while low levels of CXCR1 are associated with increased incidence of acute pyelonephritis. Current research is focused on the identification of additional virulence factors and therapeutic or prophylactic targets that might be used in the generation of vaccines against both uropathogens.

Entities:  

Mesh:

Year:  2010        PMID: 20647992     DOI: 10.1038/nrurol.2010.101

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  187 in total

Review 1.  Lateral gene transfer and the nature of bacterial innovation.

Authors:  H Ochman; J G Lawrence; E A Groisman
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

2.  Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization.

Authors:  Kelly J Wright; Patrick C Seed; Scott J Hultgren
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

3.  CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli.

Authors:  Ke Li; Maria Jose Feito; Steven H Sacks; Neil S Sheerin
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

4.  Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.

Authors:  E V Valore; C H Park; A J Quayle; K R Wiles; P B McCray; T Ganz
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

Review 5.  Host subversion by formation of intracellular bacterial communities in the urinary tract.

Authors:  Gregory G Anderson; Steven M Martin; Scott J Hultgren
Journal:  Microbes Infect       Date:  2004-10       Impact factor: 2.700

6.  Cutting edge: FimH adhesin of type 1 fimbriae is a novel TLR4 ligand.

Authors:  Karen L Mossman; M Firoz Mian; Nicole M Lauzon; Carlton L Gyles; Brian Lichty; Randy Mackenzie; Navkiran Gill; Ali A Ashkar
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  Glycolipid depletion in antimicrobial therapy.

Authors:  Majlis Svensson; Björn Frendeus; Terry Butters; Frances Platt; Raymond Dwek; Catharina Svanborg
Journal:  Mol Microbiol       Date:  2003-01       Impact factor: 3.501

8.  Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model.

Authors:  N Moayeri; C M Collins; P O'Hanley
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

9.  Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility.

Authors:  Melanie M Pearson; Mohammed Sebaihia; Carol Churcher; Michael A Quail; Aswin S Seshasayee; Nicholas M Luscombe; Zahra Abdellah; Claire Arrosmith; Becky Atkin; Tracey Chillingworth; Heidi Hauser; Kay Jagels; Sharon Moule; Karen Mungall; Halina Norbertczak; Ester Rabbinowitsch; Danielle Walker; Sally Whithead; Nicholas R Thomson; Philip N Rather; Julian Parkhill; Harry L T Mobley
Journal:  J Bacteriol       Date:  2008-03-28       Impact factor: 3.490

10.  Identification and characterization of a novel uropathogenic Escherichia coli-associated fimbrial gene cluster.

Authors:  Eric L Buckles; Farah K Bahrani-Mougeot; Anita Molina; C Virgina Lockatell; David E Johnson; Cinthia B Drachenberg; Valerie Burland; Fred R Blattner; Michael S Donnenberg
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

View more
  143 in total

1.  Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection.

Authors:  Sébastien Crépin; Sébastien Houle; Marie-Ève Charbonneau; Michaël Mourez; Josée Harel; Charles M Dozois
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

2.  Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection.

Authors:  Magnus Steigedal; Anne Marstad; Markus Haug; Jan K Damås; Roland K Strong; Pacita L Roberts; Stephanie D Himpsl; Ann Stapleton; Thomas M Hooton; Harry L T Mobley; Thomas R Hawn; Trude H Flo
Journal:  J Immunol       Date:  2014-11-14       Impact factor: 5.422

Review 3.  Asymptomatic bacteriuria: when the treatment is worse than the disease.

Authors:  Barbara W Trautner
Journal:  Nat Rev Urol       Date:  2011-12-06       Impact factor: 14.432

Review 4.  The emerging threat of multidrug-resistant Gram-negative bacteria in urology.

Authors:  Hosam M Zowawi; Patrick N A Harris; Matthew J Roberts; Paul A Tambyah; Mark A Schembri; M Diletta Pezzani; Deborah A Williamson; David L Paterson
Journal:  Nat Rev Urol       Date:  2015-09-01       Impact factor: 14.432

Review 5.  Innate Immune Responses to Bladder Infection.

Authors:  Byron W Hayes; Soman N Abraham
Journal:  Microbiol Spectr       Date:  2016-12

6.  Escherichia coli CFT073 Fitness Factors during Urinary Tract Infection: Identification Using an Ordered Transposon Library.

Authors:  Allyson E Shea; Juan Marzoa; Stephanie D Himpsl; Sara N Smith; Lili Zhao; Lisa Tran; Harry L T Mobley
Journal:  Appl Environ Microbiol       Date:  2020-06-17       Impact factor: 4.792

7.  Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation.

Authors:  Francis M Hughes; Nivardo P Vivar; James G Kennis; Jeffery D Pratt-Thomas; Danielle W Lowe; Brooke E Shaner; Paul J Nietert; Laura S Spruill; J Todd Purves
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-27

Review 8.  The nature of immune responses to urinary tract infections.

Authors:  Soman N Abraham; Yuxuan Miao
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

9.  Intracellular bacteria in the pathogenesis of Escherichia coli urinary tract infection in children.

Authors:  Luciana Robino; Paola Scavone; Lucia Araujo; Gabriela Algorta; Pablo Zunino; María Catalina Pírez; Rafael Vignoli
Journal:  Clin Infect Dis       Date:  2014-08-04       Impact factor: 9.079

10.  High resolution electron microscopy of the Helicobacter pylori Cag type IV secretion system pili produced in varying conditions of iron availability.

Authors:  Kathryn Patricia Haley; Eric Joshua Blanz; Jennifer Angeline Gaddy
Journal:  J Vis Exp       Date:  2014-11-21       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.